Public feedback to shape Plan S implementation guidance
Feedback on the implementation guidance for Plan S highlights key themes for consideration.
Should pharmaceutical companies be doing more to advocate open access?
Many public funders have mandated open access to their research and support Plan S. Should pharmaceutical companies follow suit?
China backs the Plan S open access initiative
China has pledged its support for Plan S, an initiative striving to make the results of publicly funded research freely available immediately on publication.